---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-122575"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:50:54.204450+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q3 revenue $312.7M (+19% YoY); raises FY2024 guidance on Adj. EBITDA to $105-115M

## Summary
- Revenue $312.7M (+19% YoY); net loss improved to $6.0M from $61.6M; Adjusted EBITDA $30.7M (+110%).
- Clinician base 7,269 (+13% YoY); visit volumes 2.0M (+15%); Center Margin $100.4M (32.1% of revenue, +32%).
- FY2024 guidance raised: revenue $1.228B-$1.248B; Adj. EBITDA $105M-$115M; positive Free Cash Flow reiterated.
- Q4 2024 guidance: revenue $302.5M-$322.5M; Adj. EBITDA $18M-$28M.

## SEC filing metadata
- accession: 0000950170-24-122575
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/0000950170-24-122575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/lfst-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-122575
- JSON: https://secwatch.observer/filing/0000950170-24-122575.json
- Plain text: https://secwatch.observer/filing/0000950170-24-122575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.